Related Experiment Video

Updated: Apr 22, 2026

Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
11:24

Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation

Published on: July 3, 2015

10.6K

Role of CHK2 inhibitors in the cellular responses to ionizing radiation

Mona Haddad Zahmatkesh, Seyed Jalal Hosseinimehr, Hamid Mahdiuni1

  • 1Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. sjhosseinim@yahoo.com.

Mini Reviews in Medicinal Chemistry
|October 14, 2014
PubMed

Insights

Checkpoint kinase 2 (CHK2) inhibitors show promise in cancer therapy by enhancing radiation effectiveness and protecting normal cells. This review evaluates recent CHK2 inhibitors for their potential as novel radiation modifiers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy

Background:

  • Ionizing radiation damages cancer cell DNA, inhibiting tumor growth.
  • Cellular response involves checkpoint kinases like CHK2, crucial for DNA repair and cell-cycle arrest.
  • CHK2 inhibitors are emerging as potential radiation modifiers in cancer treatment.

Purpose of the Study:

  • To review and discuss the latest CHK2 inhibitors.
  • To evaluate the chemical structures and biological activities of these inhibitors.
  • To assess their role in modulating cell growth during ionizing radiation exposure.

Main Methods:

  • Literature review of recent studies on CHK2 inhibitors.
  • Analysis of chemical structures and biological activities.
  • Evaluation of their impact on cellular responses to radiation.

Main Results:

  • Recent CHK2 inhibitors demonstrate potential in sensitizing cancer cells to radiation.
  • These inhibitors may also offer radioprotection for normal tissues.
  • Specific chemical structures correlate with varying biological activities and therapeutic potential.

Conclusions:

  • CHK2 inhibitors represent a promising strategy for improving cancer radiotherapy.
  • Further research into their structure-activity relationships is warranted.
  • These agents could enhance treatment efficacy and reduce side effects.

More Related Videos

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells05:18

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Published on: June 9, 2020

10.9K
Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry08:21

Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry

Published on: September 1, 2019

12.3K

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K